CTHRC1 mediates IL‑1β‑induced apoptosis in chondrocytes via JNK1/2 signaling

  • Authors:
    • Qi Zhang
    • Zong‑Sheng Yin
    • Fu‑Wen Zhang
    • Kun Cao
    • He‑Yan Sun
  • View Affiliations

  • Published online on: January 18, 2018     https://doi.org/10.3892/ijmm.2018.3403
  • Pages: 2270-2278
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Osteoarthritis (OA), also known as degenerative joint disease or degenerative arthritis, is characterized by chondrocyte apoptosis. The aim of the present study was to investigate the effects of collagen triple helix repeat containing 1 (CTHRC1) and the c‑Jun N‑terminal kinase (JNK) 1/2 inhibitor SP600125 on rat chondrocytes cultured in vitro with interleukin (IL)‑1β. Chondrocytes were treated with different doses of IL‑1β and cell viability and CTHRC1 expression were assessed using Cell Counting Kit‑8 and western blot assays, respectively. In separate experiments, chondrocytes were treated with CTHRC1‑expressing constructs (pLVX‑Puro‑CTHRC1) and/or SP600125, or IL‑1β with either CTHRC1 short hairpin (sh)RNA constructs (shNRA‑CTHRC1) or SP600125. The expression of CTHRC1, B‑cell lymphoma (Bcl)‑2, Bcl‑2‑associated X protein (Bax), cleaved caspase‑3, poly ADP ribose polymerase (PARP)‑1 and matrix metalloproteinase (MMP)‑13 was measured using reverse transcription‑quantitative polymerase chain reaction and western blotting assays. A Cell Counting Kit‑8 assay was performed to examine cell viability. Annexin V/propidium iodide staining and flow cytometry assays were used to detect chondrocyte apoptosis. The expression of JNK1/2 and phosphorylated JNK1/2 was measured using western blotting. CTHRC1 was highly expressed in patients with OA compared with normal controls. IL‑1β treatment (5, 10 and 20 ng/ml) increased the protein expression of CTHRC1 in a dose‑dependent manner and decreased the viability of chondrocytes in a time‑dependent manner. pLVX‑Puro‑CTHRC1 mimics the effect of IL‑1β on chondrocyte apoptosis and JNK1/2 activity, and this is reversed by SP600125 treatment. However, transfection with shRNA‑CTHRC1 or treatment with SP600125 inhibited IL‑1β‑induced cell apoptosis and JNK1/2 activation. These results indicate that CTHRC1 downregulation may protect chondrocytes from IL‑1β‑induced apoptosis by inactivating the JNK1/2 pathway.
View References

Related Articles

Journal Cover

April-2018
Volume 41 Issue 4

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Q, Yin ZS, Zhang FW, Cao K and Sun HY: CTHRC1 mediates IL‑1β‑induced apoptosis in chondrocytes via JNK1/2 signaling. Int J Mol Med 41: 2270-2278, 2018
APA
Zhang, Q., Yin, Z., Zhang, F., Cao, K., & Sun, H. (2018). CTHRC1 mediates IL‑1β‑induced apoptosis in chondrocytes via JNK1/2 signaling. International Journal of Molecular Medicine, 41, 2270-2278. https://doi.org/10.3892/ijmm.2018.3403
MLA
Zhang, Q., Yin, Z., Zhang, F., Cao, K., Sun, H."CTHRC1 mediates IL‑1β‑induced apoptosis in chondrocytes via JNK1/2 signaling". International Journal of Molecular Medicine 41.4 (2018): 2270-2278.
Chicago
Zhang, Q., Yin, Z., Zhang, F., Cao, K., Sun, H."CTHRC1 mediates IL‑1β‑induced apoptosis in chondrocytes via JNK1/2 signaling". International Journal of Molecular Medicine 41, no. 4 (2018): 2270-2278. https://doi.org/10.3892/ijmm.2018.3403